Jonathan A. Bernstein, MD
2 clinical trials · Sponsor
◉ Watch Jonathan A. Bernstein, MD
| Record | Firm | Date |
|---|---|---|
| The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment (NCT04358224) | Jonathan A. Bernstein, MD | 2020-09-01 |
| Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody (NCT03183024) | Jonathan A. Bernstein, MD | 2017-09-12 |
Track Jonathan A. Bernstein, MD automatically
Every clearance here is in the API, with alerts when new ones post.